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Abstract:  
The growth in information technology and computer capacity has opened up opportunities to deal with much 
and much larger data sets than even a decade ago.  There has been a technological revolution of big data and 
Artificial Intelligence (AI).  Perhaps many readers would immediately think about robotic surgery or self-
driving cars, but there is much more to AI.  This Short Communication starts with an overview of the key 
terms, including AI, machine learning, deep learning and Big Data.   
This Short Communication highlights so developments of AI in health that could benefit a low-income country 
like Nepal and stresses the need for Nepal’s health and education systems to track such developments and 
apply them locally.  Moreover, Nepal needs to start growing its own AI expertise to help develop national or 
South Asian solutions.  This would require investing in local resources such as access to computer 
power/capacity as well as training young Nepali to work in AI.   
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Introduction 
The growth in information technology and computer capacity 
has opened up opportunities to deal with much and much 
larger data sets than even a decade ago.  There has been a 
technological revolution of big data and Artificial Intelligence 
(AI).  Perhaps many readers would immediately think about 
robotic surgery or self-driving cars, but there is much more to 
AI.  This Short Communication starts with an overview of the 
key terms, including AI, machine learning, deep learning and 
Big Data.  
AI as a discipline sets the goal of designing systems capable of 
reproducing the behaviour of humans in their reasoning 
activities. Such systems are usually referred to as intelligent 
systems. Often, such systems need a mixture of hardware and 
software to acquire and apply knowledge in an “intelligent” 
way and have the capabilities of perception, reasoning, 
learning, and making inferences from existing information. 
There are two types of AI, referred to as: strong and weak. 
Strong AI aims at developing systems that actually think and 
execute tasks in the way humans do. Weak AI aims at getting 
systems to work without figuring out how human reasoning 
works. AI consists of a number of branches, including: 
machine learning, natural language processing and 
understanding, pattern recognition, machine vision, robotics, 
computer audition, and speech recognition.    
Machine learning (ML) is relevant and applicable to all 
branches for various purposes.  As a subfield of AI, ML 
investigates the mechanisms by which knowledge is acquired 
through learning from experience. In other terms, ML focuses 
on designing algorithms/systems that learn from data. Such 
learning algorithms use sample data to generate a model which 
will be used for decision making in the future from subsequent 
data emanating from the same data source. We distinguish at 
least three paradigms of ML algorithms: supervised learning 
(where learning requires the presence of the desired output – 
called the ground truth), unsupervised learning (where training 
data does not have the desired output) and reinforcement 
learning (where learning follows from a sequence of actions 
informed by interaction with the environment).  
Deep learning is a sub-class of ML methods that are largely 
based on neural networks and representation learning. 
Artificial neural networks are largely inspired by neural 
networks in the brain. Such networks are organised as layers 
of neurons interconnected by weighted links (synapses). So, 
the more layers there are, the deeper the network will be. Each 
layer transforms its input and produces an output that is sent to 
the next layer. The first layers in a deep network focus on the 
details at the smallest scales, while the following layers build  
coarse granularity by combining small-scale features at 
previous layers. The deeper the layers, the more they are able 
to represent abstract concepts. Think of learning to 
discriminate images. In a deep network architecture, the first 
layers might help isolate characteristic elements of object in 
the images, and the deeper layers will contribute to the 
emergence of the full object (e.g., person). Intermediate layers 
contribute to the formation of larger elements (nose, mouth, 
etc.) of the object. Deep learning is now considered as the 
most successful paradigm of ML and AI.  
Finally, Big Data refers to huge amounts of data that are hard 
to examine in the traditional way. In its normative definition, 
Big Data is characterised by a set of five V’s: Volume (size), 
Velocity (rapid and continuous growth), Variety (structured 
and unstructured formats), Veracity (quality), and Value 
(usefulness). The concept of Big Data analytics is about 
learning, discovering and inferring knowledge from large 
(enormous) data sets.     
AI algorithms have been successfully applied in various 
healthcare and medical domains as decision support tools for 
diagnosis to prognosis (predictive analysis) applications. For 
instance, medical imaging has been a target for AI tools, 
especially for deep learning as it is proven to be highly 
competitive to human medical performance. Application of 
deep learning has been investigated in a range of health fields 
and diseases, such radiomics, neurosurgical imaging, skin 
lesion, tumour, chest pain, neurologic diseases such as 
Alzheimer disease [1-2]. Other traditional AI and machine 
learning algorithms have also been applied to various 
diagnosis areas including breast cancer, drug discovery, 
therapy selection, and stratified care delivery. To enhance the 
efficiency of machine learning algorithms, substantially large 
datasets are required. This is particularly relevant to deep 
learning algorithms. The concept of (longitudinal) big data 
becomes quite appealing as data from different sources in 
various format (text, image, numerical, video) can be 
combined to make well-informed diagnosis or prognosis 
decisions.    
These electronic health databases can allow for a personalized 
approach to medicine by improving diagnoses and predicting 
individual therapy responses, within clinical research and 
practice this would constitute a revolution if successful. 
Although the vision of personalized medicine is exciting, we 
would argue that it still has major challenges, many of which 
cannot be overcome by algorithmic ambiguity, and call for 
collaboration between traditional methodologists and medical 
ML experts to avoid considerable research waste [3].  
AI in Health Care  
AI adds another dimension to the discipline of Epidemiology 
[4].  Epidemiology often uses large data sets to seek out the 
relative influence of a range of determinants on a patient group 
or population or to assess the prevalence and incidence of 
(rare) diseases. 
917 
 
AI and its sub-fields have impacted healthcare in many ways 
from diagnostics, triage, to treatment and planning of care. For 
example, the ability to predict a patient’s risk of having to 
undergo prolonged mechanical ventilation (PMV) can improve 
patient outcomes and reduce costs to intensive care units 
(ICUs).  For example, Abujaber and colleagues [5] designed a 
ML method which is predictive of the duration a patient will 
need to undergo PMV after experiencing a traumatic brain 
injury (TBI), thus allowing doctors to design more appropriate 
individual care plans and make an earlier decision on whether 
to perform a tracheostomy which is a key factor in patient 
outcome.  
This technological revolution could have a great impact on 
low-income countries like Nepal.  Especially if AI produces 
low cost solutions that are otherwise too expensive for most 
people in a low-income country.  We hope to present some 
examples of AI progress that can be employed in Nepal.   
Birth asphyxia is one of the highest causes of new-born 
mortality worldwide with blood gas analysis of arterial blood 
being the confirmatory clinical diagnosis. However, this is an 
often-cost-prohibitive and unavailable technology in low-
income countries resulting in a disproportionality high number 
of new-born asphyxia deaths occurring in low- and middle-
income countries due the delayed diagnosis which comes after 
visual symptoms have emerged. Significant delay in 
diagnosing asphyxia and reversing may leave the patient with 
permanent brain damage. Ubenwa, a mobile phone app is 
being developed and tested in Nigeria which provides a 
machine learning algorithm (support vector classifier) which 
classifies new-born cries to identify asphyxia, this diagnostic 
tool provides the diagnosis with 20 seconds and allows an 
earlier intervention with only the requirement of a mobile 
phone, a tool rapidly growing in circulation within low income 
countries [6]. The model in Nigeria is trained on new-born 
cries recorded directly by doctors in Mexico [7] which goes to 
demonstrate the geographically transitive power of these tools. 
Diabetic eye disease is a very common diseases in 
Ophthalmology and is a growing public health issue. The 
incidence of vision-threatening diabetic retinopathy in high-
income countries is declining, combining improved diabetic 
management and ophthalmological treatment, but globally it is 
increasing in low-income countries [8].  With findings that 
greatly enhance early detection and widening digital imaging 
(high resolution retinal photography and optical consistency 
tomography), combined with the potential for permanent 
morbidity, diabetic retinopathy is an excellent screening 
candidate. As far as we know  it is the first medical device that 
is permitted to make a screening decision without clinician 
supervision, stratifying patients from those needing 
ophthalmology testing to patients who do not need yearly 
screening.  
In dermatology recognizing visual pattern recognition is a key 
diagnostic skill, and AI has the potential to increase image 
perception and enhance diagnostic accuracy [9]. New neural 
computational networks have been used to diagnose skin 
disorders through visual image recognition, showing 
sometimes higher sensitivity and accuracy than professionally 
trained dermatologists. This field particularly can benefit from 
the work already carried in digital image processing and AI 
interpreted computer imagery.  
In the current Covid-19 pandemic, many are seeking 
conventional as well as AI solutions [10].  One conventional 
Public Health measure is regular antibodies testing of a subset 
of a population.  However, this is an expensive method 
confounded by the limit number of test kits the world can 
produce each day and how they are distributed across high, 
middle and low income countries. Online search trends are a 
possible pseudo-diagnosis of a population, of the Covid-19 
symptoms and their associated probabilities of occurrence.   
Lampos et al. trained a transfer machine learning model (with 
Italian data to train each model prior to training on the relevant 
countries’ data).  This model provides a good estimate of trend 
in number of daily confirmed cases in six countries [11]. This 
low budget tracking method provides a resource for low and 
middle-income nations to track the prevalence of the disease in 
their countries and take preventative measures, as well as 
evaluated past measures in accordance with the severity of the 
situation. Training an algorithm to predict outcomes such as 
death, admission to intensive care units or the need for 
mechanical ventilation can have a major clinical effect.  ML 
algorithms and procedures are also versatile, new algorithms 
designed during this pandemic may be used for other 
respiratory diseases in the future. 
In terms of patient care AI can be used to rapidly transfer 
knowledge between institutions on a global scale. An example 
of this is ultrasound, a widely used imaging method that is 
applied in a wide range of sub-specialties. High-quality 
ultrasound images are the basis of expert interpretation, 
however AI is helping to provide a route for capturing of 
images automatically, even uninitiated and has the potential to 
diagnose and monitor COVID-19 patients via ultrasound of 
the lungs, without having to teach health workers how to 
interpret results [12]. 
Clinical Trials and AI 
The inclusion of AI solutions in clinical trials is a relatively 
new phenomenon. The 2013 SPIRIT (Standard Protocol Items: 
Recommendations for Interventional Trials) statement aims to 
increase clinical trial reporting by offering evidence-based 
guidance on the minimum number of items to be addressed 
[13], in order to promote a transparent appraisal of new 
therapies. Like any new therapy, AI-based health interventions 
need to be systematically assessed to demonstrate their 
effectiveness. The SPIRIT-AI Extension is the recognized 
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guideline for clinical trial protocols on AI-component 
interventions and includes 15 new essential elements. SPIRIT-
AI encourages researchers to be transparent and clearly 
describe the AI intervention, including instructions and the 
required skills, the context in which the AI intervention will be 
implemented, data management issues, human-AI interaction 
and error case analysis. In addition, SPIRIT-AI will help 
journal editors, peer reviewers and readers to understand, 
evaluate and critically assess the design and risk of bias in a 
clinical trial.  
The way forward 
In conclusion, there will be many AI solutions in health care 
currently under development or already in use elsewhere that 
can be applied to low-income countries.  It is important for a 
country like Nepal to track such developments and apply them 
locally.  This requires policymakers, health care providers 
(public and private) and universities to put an effort into 
staying up-to-date with global development in this field.   
Secondly, we recommend that Nepal starts growing its own AI 
expertise to develop national or South Asian solutions.  This 
would require local resources for example to access computer 
power/capacity as well as training young Nepali to work in AI.  
Studying epidemiology is good first step, but profiling and in-
depth statistical analysis of large data set are different from 
machine learning. 
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